Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.55 USD | +5.31% | +27.59% | +131.25% |
May. 02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 02 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 1.02B | Sales 2025 * | 1.14B | Capitalization | 291M |
---|---|---|---|---|---|
Net income 2024 * | -155M | Net income 2025 * | -110M | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 111M | Net Debt 2025 * | 336M | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-1.85
x | P/E ratio 2025 * |
-2.64
x | Employees | 1,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent BioSolutions Inc.
1 day | +5.31% | ||
1 week | +27.59% | ||
Current month | +195.21% | ||
1 month | +192.11% | ||
3 months | +255.77% | ||
6 months | +170.73% | ||
Current year | +131.25% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 61 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 25 M€ | -1.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.55 | +5.31% | 2,484,981 |
24-05-16 | 5.27 | -7.71% | 1,764,645 |
24-05-15 | 5.71 | +12.40% | 3,122,530 |
24-05-14 | 5.08 | -5.22% | 3,386,322 |
24-05-13 | 5.36 | +23.22% | 5,891,167 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+131.25% | 291M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- EBS Stock